State Street’s Trinity Biotech TRIB Stock Holding History

State Street’s Portfolio TRIB Stock Details TRIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-23,518	Closed	-$142K	–	3827
2019 Q3	$142K	Hold	23,518	–	–	﹤0.01%	3637
2019 Q2	$218K	Hold	23,518	–	–	﹤0.01%	3604
2019 Q1	$335K	Hold	23,518	–	–	﹤0.01%	3507
2018 Q4	$269K	Hold	23,518	–	–	﹤0.01%	3530
2018 Q3	$470K	Sell	23,518 -4,059	-15%	-$88.2K	﹤0.01%	3486
2018 Q2	$689K	Sell	27,577 -996	-3%	-$24K	﹤0.01%	3437
2018 Q1	$736K	Sell	28,573 -78	-0.3%	-$2.13K	﹤0.01%	3383
2017 Q4	$731K	Buy	28,651 +21,050	+277%	+$543K	﹤0.01%	3400
2017 Q3	$213K	Buy	7,601 +78	+1%	+$2.18K	﹤0.01%	3598
2017 Q2	$225K	Buy	7,523 +156	+2%	+$4.42K	﹤0.01%	3524
2017 Q1	$219K	Buy	7,367 +256	+4%	+$8.01K	﹤0.01%	3494
2016 Q4	$246K	Buy	7,111 +257	+4%	+$8.85K	﹤0.01%	3478
2016 Q3	$453K	Sell	6,854 -137	-2%	-$8.53K	﹤0.01%	3304
2016 Q2	$396K	Buy	6,991 +3,508	+101%	+$198K	﹤0.01%	3423
2016 Q1	$203K	Sell	3,483 -144	-4%	-$7.64K	﹤0.01%	3487
2015 Q4	$214K	Buy	3,627 +73	+2%	+$4.31K	﹤0.01%	3473
2015 Q3	$204K	Sell	3,554 -125	-3%	-$10.1K	﹤0.01%	3466
2015 Q2	$332K	Buy	3,679 +53	+1%	+$4.59K	﹤0.01%	3421
2015 Q1	$349K	Buy	3,626 +156	+4%	+$14.4K	﹤0.01%	3419
2014 Q4	$304K	Sell	3,470 -145	-4%	-$12.5K	﹤0.01%	3472
2014 Q3	$330K	Buy	+3,615	New	+$391K	﹤0.01%	3424

Other funds holding TRIB

SCM

Stonehill Capital Management New York $197M AUM 96.45% 1-Year Est. Return

PIM

Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return

HAIM

Hunter Associates Investment Management Pittsburgh, Pennsylvania $756M AUM 19.99% 1-Year Est. Return

Fondren Management Houston, Texas $16.9M AUM 5.82% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return

FWSM

First Wilshire Securities Management Pasadena, California $444M AUM 42.88% 1-Year Est. Return

ICM

Invenomic Capital Management Boston, Massachusetts $2.18B AUM 0.03% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

ARM

Adirondack Research & Management Guilderland, New York $82.2M AUM 63.78% 1-Year Est. Return

State Street's TRIB Position: Q4 2019 in Review

State Street sold out of Trinity Biotech (TRIB) in Q4 2019, closing a stake of 23,518 shares — an estimated $142K sold.

State Street first reported a position in TRIB in Q3 2014 and held it in 21 quarters. The position peaked at $736K in Q1 2018. 26 funds tracked by Wall St. Rank hold TRIB as of Q4 2019.

State Street reported no remaining Trinity Biotech position as of Q4 2019 after selling out during the quarter.
State Street sold 23,518 Trinity Biotech shares in Q4 2019, an estimated $142K.
State Street first reported a position in Trinity Biotech in Q3 2014 and held it in 21 quarters.
State Street's Trinity Biotech position peaked at $736K in Q1 2018.
26 funds tracked by Wall St. Rank held Trinity Biotech as of Q4 2019.

Based on State Street's 13F filing for Q4 2019, filed 6 Feb 2020.